Arcturus self-amplifying RNA: US approval expected this year.
saRNA platform Kostaive is already approved in Europe and Japan and is being tested in the US now.
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a commercial mRNA medicines and vaccines company with enabling technologies:
LUNAR® lipid-mediated delivery;
STARR® mRNA technology (sa-mRNA);
mRNA drug substance and drug product manufacturing.
Arcturus KOSTAIVE, a self-amplifying messenger RNA (sa-…
